study question: Does calcium oscillatory pattern analysis following heterologous intra-cytoplasmic sperm injection (ICSI) of human sperm into mouse oocytes lead to diagnostic and prognostic information for patients suffering from ICSI fertilization failure?
Introduction
Intra-cytoplasmic sperm injection (ICSI) is a very efficient assisted reproduction technique with a mean fertilization rate of 70-80% (Palermo et al., 2009) . Nevertheless, 1-3% of the couples experience total fertilization failure after ICSI or low fertilization rates in recurrent cycles, even when a sufficient number of mature oocytes and motile sperm are available (Esfandiari et al., 2005) . Failure of oocyte activation is the most common cause of fertilization failure following ICSI (Liu et al., 1995; Flaherty et al., 1998; Rawe et al., 2000; Yanagida, 2004) . Oocyte activation consists of a series of events, which result in the release of the oocyte from its metaphase II (MII) arrested state and leads to further embryo development. It has been claimed that upon fertilization in mammals, the sperm factor phospholipase C zeta (PLCzeta) triggers long-lasting intracellular calcium oscillations in the oocyte's cytosol. PLCzeta stimulates a phosphoinositide signalling pathway, leading to an increase in inositol-triphosphate (IP3), which binds its receptors on intracellular calcium stores and eventually induces oscillatory calcium release . The specific pattern of these calcium oscillations differs only slightly between species and is considered pivotal for successful oocyte activation and embryonic development (Ducibella et al., 2002; Ozil et al., 2006; Kashir et al., 2010) . The ability of the mammalian oocyte to generate calcium oscillations and respond to them is developed during final mammalian oocyte maturation (Ajduk et al., 2008) . Hence, both the sperm and the oocyte play a role in oocyte activation, fertilization and further embryo development (Tesarik and Mendoza, 1999) .
The mouse oocyte activation test (MOAT), a heterologous ICSI model, evaluates the oocyte activation capacity of human sperm (Rybouchkin et al., 1996a) . The MOAT compares the activation percentage of mouse oocytes after injection of sperm from the patient versus control sperm with proven activation capacity. The MOAT enabled the classification of patients with failed or low fertilization after ICSI into three groups: (i) patients with a mouse oocyte activation percentage of 20% or less (i.e. the upper limit of the negative control) are classified as the low activating group (MOAT group 1 patients); (ii) patients in which 21-84% of the mouse oocytes are activated are classified as the intermediate activating group (MOAT group 2 patients); and (iii) if 85% or more of the mouse oocytes are activated (i.e. the lower limit of the positive control), patients are classified as the high activating group (MOAT group 3 patients). In MOAT group 1 patients, a sperm-related deficiency is likely to be at the origin of previous fertilization failures, while in MOAT group 3 patients a sperm-related deficiency can most probably be refuted. For MOAT group 2 patients, the MOAT reveals a reduced activation capacity of the patient's spermatozoa. In the latter cases, the MOAT result is called inconclusive; hence, both sperm and oocyte deficiencies may still contribute to the previous ICSI fertilization failure in those couples.
Recently, there has been growing interest in the use of assisted oocyte activation (AOA) in patients suffering from previous total fertilization failure or low fertilization following conventional ICSI (Nasr-Esfahani et al., 2010) . Several activating agents, such as calcium ionophore, strontium ions and electrical pulses, have proved to be efficient in restoring fertilization and pregnancy rates (Yanagida et al., 1999 (Yanagida et al., , 2006 Eldar-Geva et al., 2003; Chi et al., 2004; Heindryckx et al., 2005) . Others reported the use of a mechanically modified ICSI technique to overcome activation failure (Tesarik et al., 2002; Ebner et al., 2004) . In our centre, AOA is performed using ionomycin, which enables us to restore fertilization rates to normal in most, but not all, patients with a history of previously failed or low fertilization (Heindryckx et al., 2005 (Heindryckx et al., , 2008 Vanden Meerschaut et al., 2012) .
Currently, the MOAT or similar heterologous ICSI models are the only diagnostic tests available to evaluate the oocyte-activating capacity of human sperm cells. Sperm from patients who consistently fail ICSI may be deficient in their potential to induce calcium oscillations in the injected oocyte. Alternatively, the problem may reside in the oocyte that fails to respond to the sperm factor and/or has the inability to initiate crucial downstream pathways. We specifically aimed to determine whether failure or low fertilization after ICSI in patients correlates with the inability of human sperm to induce proper calcium oscillations in mouse oocytes. Furthermore, the results of the calcium oscillatory pattern analysis were correlated with the previous MOAT results and classification, in order to evaluate the diagnostic potential and possible added value of calcium analysis, especially for MOAT group 2 patients, for whom the MOAT result was called inconclusive. We hypothesized that calcium oscillatory pattern analysis has the strength to confirm a sperm-borne activation deficiency in patients with a former intermediate inconclusive MOAT result and, more importantly, is able to reveal, on an individual patient level, the underlying reason for low or failed fertilization after conventional ICSI.
Materials and Methods

Patient selection
Patients with a history of low or failed fertilization following conventional ICSI were eligible for this study. Three patients were diagnosed with total globozoospermia elsewhere and had not undergone any ICSI treatment yet, before they were referred to our centre. All the included patients underwent their MOAT between 2004 and 2011. Calcium oscillatory pattern analysis was performed between January and December 2011 with sperm from MOAT group 1 (n ¼ 7), MOAT group 2 (n ¼ 10) and MOAT group 3 patients (n ¼ 9). The clinical outcome and efficiency of AOA had been analysed before for seven out of nine of the included MOAT group 3 patients (cases 3.1, 3.3, 3.4, 3.5, 3.6, 3.7 and 3.8; Vanden Meerschaut et al., 2012) . Furthermore, sperm from four control patients, with proved fertilization capacity after conventional ICSI, was analysed the same way.
Ethical approvals
Patient selection was based on the availability of sperm for research after obtaining written informed consent from the patients as approved by the Ethical Committee of Ghent University Hospital (2010/808). The use of laboratory animals was approved by the Animal Ethical Committee of Ghent University (ECD 10/26).
Oocyte source and recovery
MII mouse oocytes were collected from 7-to 10-week-old B6D2 F1 hybrid female mice after ovulation induction by intra-peritoneal injection of 10 IU of pregnant mare serum gonadotrophin (PMSG, Folligon w , Intervet, Boxmeer, The Netherlands), followed 46 -48 h later by 10 IU of hCG (Chorulon w , Intervet, Boxmeer, The Netherlands). MII oocytes were collected 13 -14 h following hCG administration. For each experiment, the oocytes from two to three superovulated mice were pooled. Culture and manipulation media were protein-free potassium simplex optimized medium (KSOM) and HEPES-buffered KSOM (KSOM-HEPES), respectively, supplemented with 0.4% bovine serum albumin (MP Biochemicals, Asse-Relegem, Belgium). Cumulus cells were removed by a brief exposure to 200 IU/ml hyaluronidase. Eventually, the oocytes were put in KSOM for culture until further manipulations.
Semen source, preparation and ICSI
Semen samples were analysed at the moment of freezing (between 2004 and 2011) according to the World Health Organization reference values for human semen characteristics (World Health Organization, 1999; Cooper et al., 2010) . Fresh control samples were collected at the moment of ICSI treatment. One part was used freshly; another part was frozen for the comparison of calcium oscillatory patterns after freezing -thawing. Frozen-thawed semen samples from patients with fertilization failure (MOAT patients) were taken from a batch of straws that had been frozen for MOAT before, independently from the ICSI treatment. Usually, a MOAT is done closely before the ICSI treatment in our centre, so semen samples for MOAT/calcium oscillatory pattern analysis and ICSI are comparable. The samples were washed once with fertilization medium by centrifugation at 330g for 10 min. Sperm was resuspended in injection medium consisting of KSOM-HEPES and added to an equal volume of 8% polyvinylpyrrolidone (PVP, ICSI-100, Vitrolife, Scandinavia) in a 5 ml drop. Only motile spermatozoa were selected for ICSI. Spermatozoa were injected after mechanical immobilization alone or additionally treated with the plasma membrane disrupting agent L-a-lysophosphatidylcholine, Lyso-PC, (Instruchemie -Avanti Polar Lipids, Delfzyl, The Netherlands) right before injection. Motile spermatozoa were mechanically immobilized and picked up (in groups of 2 -4), demembranated in 0.02% Lyso-PC for 1 min, washed in PVP and immediately injected into mouse oocytes using piezo pulses. Either (i) fresh or frozen -thawed sperm mechanically immobilized, treated or not with Lyso-PC, from patients with proven activation capacity (control) or (ii) frozen -thawed mechanically immobilized and Lyso-PC treated sperm from patients with a known MOAT result were tested. For each experiment using frozen-thawed sperm from a MOAT patient, one control group of 10 oocytes was injected with control sperm to ascertain reliable settings during that particular experiment.
Calcium imaging
MII mouse oocytes were loaded with the Ca 2+ -sensitive fluorescent dye fura-2 acetoxymethyl ester (fura-2 AM, cat.no. F1201, Invitrogen, Merelbeke, Belgium) by incubating them in KSOM-HEPES containing 7.5 mM fura-2 AM for 20 min at 378C and 10 min at room temperature. After washing, the oocytes were put in an ICSI dish in KSOM-HEPES supplemented with 20% fetal bovine serum (Gibco BRL, Invitrogen, Belgium). The oocytes were cooled down for 10 min on a cooled stage (15-178C) before starting piezo-driven ICSI. After ICSI the oocytes were put in a microdrop of KSOM-HEPES covered with mineral oil on a 35 mm diameter glass bottom dish (MatTek Corp., cat.no. P35G-0 -14-C, Ashland, USA). Imaging was performed on a heated stage (378C) on an inverted epifluorescence microscope (Nikon Eclipse TE 300, Analis Ghent, Belgium) with a 20× objective and a filter switch (Lambda DG-4 filterswitch, Sutter Instrument Company, Novato, CA, USA), providing excitation alternating between 340 and 380 nm for fura-2 AM. On average, groups of 10 oocytes were measured simultaneously and imaging started within 5-10 min after the end of ICSI. Images were acquired every 5 s over a time period of 2 h making use of an electron-multiplying charge-coupled device camera (Quantem 512SC, Photometrics, Tucson, AZ, USA). Ratio images were generated off-line with software written in Microsoft Visual C++ 6.0, after standard background and shade correction procedures. The intracellular calcium levels were recorded in terms of the ratio of fluorescence (340/380 nm), which rises with increasing intracellular calcium concentration. For comparison between different sperm sources, the frequency of the calcium oscillatory pattern was scored per oocyte as follows (similarly to a previously used classification by Yoon et al. (2008) ): no calcium spike (score '0'), 1-2 spikes (score '+'), 3-10 spikes (score '++') and more than 10 spikes (score '+++') within 2 h immediately following ICSI. Representative traces are shown in Fig. 1 . After the frequency scoring, the raw frequency of each oocyte was examined (amount of calcium spikes/2 h). Finally, the relative amplitude of the calcium spikes of each individual oscillating oocyte was calculated as the change in the fura-2 fluorescence ratio divided by the baseline ratio: DR/R (%).
Statistical analyses
Proportions (frequency scoring '0', '+', '++', '+++') were compared by a contingency table analysis followed by a x 2 test. Means (raw frequency, relative amplitude and the product of both) were compared using one-way analysis of variance (ANOVA) followed by pair-wise comparisons using the Mann-Whitney U-test. A P-value lower than 0.05 was considered statistically significant (SPSS w Statistics 19, IBM Corp., New York, USA). Curve fitting of the data was done by a non-linear least squares Levenberg-Marquardt procedure as described in Teukolsky et al. (1992) .
Results
Ability of human control sperm to induce calcium oscillations in mouse oocytes
To obtain a standard calcium response pattern after injection of human sperm into mouse oocytes, human sperm from four patients with proven activation potential were used. Table I shows their fertilization rates, semen characteristics and clinical outcome. Preliminary experiments showed that when control human sperm was mechanically immobilized and injected into mouse oocytes, the calcium responses were frequently absent: only 4 out of 35 (11.4%) mouse oocytes displayed repetitive (oscillatory) calcium spikes within the 2 h time interval following ICSI. In contrast, when the same human sperm were mechanically immobilized and subsequently demembranated with 0.02% L-a-lysophosphatidylcholine (Lyso-PC; as reported by Morozumi et al., 2006) immediately before ICSI, calcium oscillations appeared in 28 out of 30 (93.3%) of the mouse oocytes. Therefore, Lyso-PC treatment was used in all further experiments.
We next verified if we could use frozen sperm for our experiments and determined whether freezing -thawing of human control sperm influences the potential to trigger calcium spiking in mouse oocytes. After heterologous ICSI with Lyso-PC-treated fresh or frozenthawed control sperm from the same patients, oscillatory calcium changes were invariably present at the start of the recordings. A typical response was characterized by a calcium oscillation frequency in the order of 5 -10 spikes per 10 min that continued for at least 60-80 min; thereafter, the frequency decreased (1-5 spikes each 10 min) or the oscillatory activity ceased. The relative calcium amplitude, expressed as the fura-2 AM ratio change relative to the baseline ratio (DR/R), did not differ between the oocytes injected with fresh or frozen-thawed control sperm: 147% (SD 23.8%) versus 131% (SD 20.8%), respectively (P ¼ 0.336). Next, the frequency of calcium oscillations within the first 2 h following ICSI was scored oocyte per oocyte. Figure 2 illustrates the result of the frequency scoring of the calcium oscillatory patterns observed after injection of fresh control sperm (68 surviving mouse oocytes) and frozen-thawed control sperm (70 surviving mouse oocytes) obtained from the same control patients (n ¼ 4). In both groups, .50% of the oocytes showed more than 10 calcium spikes during the 2 h measurement period (score '+++'). No difference in frequency scoring was found following injection of fresh versus frozen-thawed control sperm from the same four patients (P ¼ 0.986, Fig. 2 , two right-most bars).
Fertility history and semen characteristics of the included MOAT patients
In total, 26 male patients presenting with no or low fertilization after conventional ICSI were included in this study. The majority of these patients were referred to our centre because of ICSI failure elsewhere. In the patients with (sub)normal semen characteristics, ICSI has not been the first-line treatment. As a matter of fact, those patients had been treated elsewhere firstly with either intrauterine insemination and/or in vitro fertilization before proceeding to ICSI. Four patients were previously diagnosed with globozoospermia; three of them did not have any previous ICSI attempt and were sent to our centre for MOAT before starting any treatment. The fertilization rates of the included patients ranged from 0 to 39.3% using conventional ICSI, with a mean fertilization rate of 16.1% (84/523) in 47 conventional ICSI attempts. Anamnesis revealed no inflammatory or other important andrological events in any of our male subjects. If a next ICSI cycle was planned in our centre, AOA was advised on all or half of the oocytes depending on the couples' history and the MOAT result, as previously described by Heindryckx et al. (2008) and Vanden Meerschaut et al. (2012) . Following ICSI combined with AOA, fertilization rates were restored in most couples giving a mean fertilization rate of 61.8% (217/351) in 35 AOA cycle attempts. Table II shows the fertilization rates before and after AOA, semen characteristics and clinical outcome of the included MOAT patients.
Calcium oscillation-inducing ability of sperm from 26 MOAT patients Four patients diagnosed with globozoospermia and 22 patients suffering from low or zero fertilization after previous conventional ICSI underwent a MOAT in order to confirm or refute a sperm-borne activation deficiency. The same semen samples were used for calcium oscillatory pattern analysis. Our goal, to measure a minimum of 10 surviving mouse oocytes per patient, was not attained in 2 out of 26 included patients (cases 2.1 and 2.7), because of an extremely low concentration of motile spermatozoa after sperm thawing. The Figure 1 Representative patterns for the calcium frequency scoring (0, +, ++, +++). The following patterns are representative traces following heterologous ICSI using frozen -thawed control sperm treated with Lyso-PC. The frequency score per oocyte is given according to the amount of calcium spikes seen during the 2 h measuring period: '+++', .10; '++', 3 -10; '+', 1 or 2; '0', no spikes seen. FT, frozen -thawed; n, amount of injected mouse oocytes that showed the particular calcium oscillatory pattern (AU, arbitrary units).
following outcome parameters for each patient group are presented in Table III : (i) frequency scoring ('0', '+', '++' or '+++'), (ii) frequency without score binning (number of calcium spikes per 2 h) and (iii) relative amplitude of the calcium spikes (DR/R, calculated from fura-2 AM measurements). It has been reported that the success of oocyte activation increases with the summation of calcium changes during the oscillations (Tó th et al., 2006) . To account for this, we calculated a fourth quantity representing the product of the relative amplitude × frequency, which reflects the summed relative amplitude of the calcium changes in the 2 h period (a dimensionless quantity). Details per included patient (MOAT and control cases) are presented in Supplementary data, Table SI .
Calcium oscillatory pattern analysis was performed in seven MOAT group 1 patients whose sperm showed no or low activating capacity (MOAT result ≤20%). In general, no or a very abnormal calcium oscillatory pattern was observed compared with the control group, with calcium responses with very low frequency seen in only 19 out of 153 (12.4%) surviving oocytes. Sperm from 4 patients with total globozoospermia were able to induce calcium spikes in 8 out of 89 (9%) surviving mouse oocytes. Of those eight responding oocytes, seven showed no more than one calcium spike (score '+') and one oocyte showed five calcium spikes (score '++'). Furthermore, sperm from a patient with no activating capacity (MOAT result 0%, patient 1.2) and an identified mutation in the PLCzeta gene (Heytens et al., 2009 ) induced a single calcium spike in 1 out of 17 (5.9%) oocytes. Conversely, sperm from 2 patients with low activation capacity (MOAT result 12 and 19%, respectively) induced calcium spikes in 10 out of 47 (21.3%) oocytes. Nevertheless, 8 out of these 10 oocytes showed ,10 calcium spikes within the measuring period (score '+' or '++').
Next, the calcium oscillatory pattern analysis of sperm from 10 patients with an intermediate inconclusive activation capacity (MOAT group 2 patients, MOAT result 21 -84%) was also evaluated. In general, the calcium oscillatory pattern for MOAT group 2 patients was very different from that of the control patients and a high degree of variability in the calcium spiking pattern for individual patients was apparent. Half of the injected and surviving oocytes showed no calcium spikes at all during the 2 h measurements. Only 36.7% of the oocytes showed higher frequency scores, '++' or '+++', compared with 74.3% of the oocytes in the frozen-thawed control group. In a large fraction of oocytes injected with MOAT group 2 sperm that did show calcium spikes, the patterns were strongly dissimilar. Irregular, broad and lower amplitude calcium spikes were most commonly seen (Fig. 3) .
Finally, sperm from 9 patients with high activation capacity (MOAT group 3 patients) was able to induce calcium oscillations in 181 out of 198 (91.4%) mouse oocytes. In 41.4% of the mouse oocytes more than 10 calcium spikes were seen within 2 h of calcium measurement (score '+++') and in 31.3% of the mouse oocytes 3-10 calcium spikes were seen (score '++').
The mean frequency scores ('0','+', '++' or '+++') for each MOAT group compared with the frozen -thawed and fresh control sperm are shown in Fig. 2 and Table III. The frequency scoring was significantly different between the frozen -thawed control group and MOAT group 1 and 2 (x 2 , P , 0.001). Interestingly, the scores for MOAT group 3 were not different from the frozen -thawed control group (x 2 , P ¼ 0.144), whereas they differed significantly from the scores of MOAT group 1 and 2 (x 2 , P , 0.001). The oscillation frequency was significantly different between the groups (ANOVA, P , 0.001) ( Table III) . The lowest oscillation frequency was seen in MOAT group 1 and 2 patients (on average 0.6 + 0.98 and 5.0 + 4.16 spikes per 2 h, respectively). MOAT group 3 and the frozen -thawed control group showed higher and similar spiking frequency, 17.4 + 13.26 and 15.3 + 7.86 spikes per 2 h, respectively (Mann -Whitney U-test, P ¼ 1).
Next, the relative amplitude (DR/R) was measured for each oocyte and within the different study groups. We found a significant difference between the study groups (ANOVA, P , 0.001) (Table III) . Again, MOAT group 1 and 2 showed lower relative amplitudes compared with MOAT group 3 and the frozen -thawed control group. The latter two groups did not differ significantly from each other (Mann -Whitney U-test, P ¼ 0.974).
Finally, the amplitude × frequency product was compared between the study groups (Table III and Fig. 4A ). MOAT group 3 showed a significantly higher product compared with MOAT group 1 and 2 (Mann -Whitney U-test, P ¼ 0.001 and 0.002, respectively). Furthermore, MOAT group 3 showed a similar amplitude × frequency product compared with the frozen -thawed control sperm (Mann -Whitney U-test, P ¼ 0.877).
Correlation between MOAT result and calcium oscillations
The MOAT result (ranging from 0 to 100%) was correlated with the amplitude × frequency product for all 26 tested MOAT patients. A plot of these two variables was characterized by a non-linear relationship ( Fig. 4B ): low MOAT percentages were associated with a low amplitude × frequency product but, when the MOAT % increased, the curve displayed at a certain point a sharp bend which was associated with a rapidly increasing amplitude × frequency product. We fitted the data points of Fig. 4B to a rectangular hyperbolic function of the form: [100 2 MOAT %] × [amplitude × frequency] ¼ C (C is a constant). This function expresses the reciprocal relation between 100 2 MOAT % and amplitude × frequency. The best fitting curve (determined by non-linear least squares fitting) was characterized by C ¼ 81 (continuous line in Fig. 4B) ; the coordinates of the vertex point of this curve were for the MOAT result 91% and for the amplitude × frequency product 9.0 (asterisk on Fig. 4B ). All data points of MOAT group 1 and all but one data point for MOAT group 2 were below the horizontal line through the vertex point (interrupted line on Fig. 4B ). MOAT group 1 is characterized by a sperm-borne deficiency while MOAT group 2 represents a grey zone between MOAT group 1 (absent activation capabilities of the sperm) and MOAT group 3 (normal activation capabilities of the sperm). The finding that the amplitude × frequency product of MOAT group 2 is significantly below the one of MOAT group 3 (Fig. 4A ) thus indicates that the calcium oscillations in group 2 are less effective in their capacity to activate oocytes. Moreover, the amplitude × frequency product of MOAT group 2 also differed significantly from the frozen-thawed control sperm (Mann-Whitney U-test, P , 0.05). In analogy with a former publication of our group (Vanden Meerschaut et al., 2012), a diagnostic and therapeutic algorithm based on the result of the calcium oscillatory pattern analysis was made (Fig. 5) .
Discussion
There is sufficient evidence that calcium oscillations are crucial for successful mammalian fertilization and further embryo development (Ducibella et al., 2002) . Thus, it is presumable that the absence of, or aberrant, calcium oscillations at the time of fertilization could lead to failed or low fertilization following ICSI. To our knowledge, this is the first study to investigate the calcium-releasing potential of human sperm in mouse oocytes in a large number of patients with zero or low fertilization following ICSI and to compare these results with the activation percentage of the same sperm in a heterologous ICSI model. Furthermore, comparison was made with a control group of ICSI patients with proven fertilization capacity. In addition, the influence of cryopreservation on the calcium-releasing ability of the sperm was evaluated. Initial experiments showed that the injection of mechanically immobilized human control sperm leads to a calcium response in only 11.4% of the mouse oocytes during the first 2 h following ICSI. In contrast, when sperm was additionally treated with Lyso-PC immediately before ICSI, almost all oocytes showed a calcium response within the 2 h measuring period. It is apparent that for oocyte activation to occur, the sperm plasma membrane has to disintegrate to let the perinuclear material blend within the ooplasm. Only when this happens, the sperm-activating factor is released and is subsequently able to target phosphatidylinositol 4,5-bisphosphate to cause an IP3 receptormediated calcium release. The influence of Lyso-PC on calcium oscillatory patterns and oocyte activation was studied before and it was Figure 2 Frequency scoring of the calcium oscillations following heterologous ICSI using MOAT sperm compared with fresh and frozen -thawed control sperm. The frequency score per oocyte is given according to the amount of calcium spikes seen during the 2 h measuring period: '+++', .10; '++', 3 -10; '+', 1 or 2; '0', no spikes seen. FT, frozen -thawed. *P , 0.001; ns, no significant difference.
shown that the plasma membrane of the human sperm is physically and biochemically very stable, e.g. more stable than that of the mouse . It was shown that the human sperm plasma membrane disintegrates more slowly when injected into mouse oocytes compared with mouse sperm plasma membrane. This could lead to delayed calcium release in our heterologous ICSI model, which would make calcium analysis less reproducible and more time consuming, because of the necessity to measure for a longer interval following ICSI. Therefore, to circumvent this problem, we used Lyso-PC to treat human sperm prior to ICSI. The choice of Lyso-PC is not surprising, since Lyso-PC is a product of hydrolysis of membrane phospholipids by phospholipase A and there is evidence that Lyso-PC plays an important role in several biological processes, including the sperm acrosome reaction (Lessig et al., 2006) .
In the current study, sperm had been frozen in cryoprotectant medium in liquid nitrogen before experimental use. A recent paper states that cryopreservation reduces the concentration of the sperm-activating factor PLCzeta in some sperm samples and had no effect on other samples (Kashir et al., 2011) . Another group showed that freezing changes the membrane integrity (Ozkavukcu et al., 2008 AOA, AOA on half of the available oocytes; morph, % of spermatozoa with normal morphology; 0, 0% spermatozoa with normal morphology, non-globozoospermia; AOA* was performed in another centre (no data regarding the exact AOA technique used). $ Singleton pregnancy from a non-AOA embryo.
Diagnostic and prognostic value of calcium oscillatory pattern analysis immobilization should be sufficient to induce early calcium oscillations in the case of frozen-thawed sperm, since membrane integrity could have been changed already by the freezing process itself. We tested this hypothesis, but no early calcium responses were seen in the majority of the injected oocytes when frozen-thawed sperm were only immobilized mechanically before ICSI. Additionally, we compared the calcium oscillatory patterns after heterologous ICSI of fresh versus frozen -thawed human control sperm from four patients with normal fertilization rates. These calcium oscillatory patterns did not differ significantly. Thus, this means that our method of cryopreservation of the sperm did not influence its calcium-releasing ability. The option of freezing sperm without a cryoprotectant to disrupt the plasma membrane was excluded, since it would not have allowed us to select live motile spermatozoa for ICSI. Moreover, it has been shown that the unprotected freezing of human spermatozoa exerts a detrimental effect on their oocyte-activating capacity (Rybouchkin et al., 1996b) .
To our knowledge, only three studies have examined the calcium oscillatory patterns in mouse oocytes after the injection of human sperm from a limited number of cases Yoon et al., 2008; Heytens et al., 2009 ). Unfortunately, in former studies the calcium oscillatory pattern was not always scored per oocyte, rather per patient, which makes comparison difficult. Therefore, a reference calcium oscillatory pattern was first determined by performing heterologous ICSI using sperm from four control patients with proven activating capacity. Yoon et al. (2008) and Heytens et al. (2009) showed that semen from patients who repeatedly failed ICSI was unable to induce typical calcium oscillatory patterns in mouse oocytes. Surprisingly, semen was frozen without a cryoprotectant before use and in none of these studies the use of Lyso-PC was mentioned. Yoon et al. (2008) determined the calcium oscillation-inducing activity of sperm from a low-fertilization patient group, containing seven patients, of which only three patients showed recurrent low fertilization rates. Not entirely unexpected, only the sperm of those three patients were unable to initiate robust calcium oscillations. In the study by Heytens et al. (2009) , sperm from three globozoospermic men was injected into mouse oocytes and the changes in intracellular calcium were measured. No calcium changes in any of the mouse oocytes were detected, even after prolonged measurement up to 4 h following heterologous ICSI. In the present study, sperm from four globozoospermic men were able to induce some, but very few, calcium spikes in some mouse oocytes. This is in agreement with the knowledge that, in men with total globozoospermia, fertilization after ICSI is extremely low, but not always absent (Dam et al., 2007) .
Both globozoospermic and normal morphology sperm with low MOAT results (MOAT group 1) failed to induce calcium oscillations in the mouse oocytes. On the other hand, sperm with normal MOAT results, and thus with high activation capacity (MOAT group 3), triggered highly frequent calcium oscillations in the majority of the injected mouse oocytes, comparable with that seen in the control sperm. Calcium oscillatory pattern analysis could thus, respectively, confirm or refute a sperm deficiency for MOAT group 1 and MOAT group 3 patients, as was expected by the previously performed MOAT activation test.
Sperm from MOAT group 2 patients, with an intermediate activation capacity, showed the greatest variability with respect to the calcium responses in mouse oocytes. Interestingly, for cases 2.1 and 2.2, the calcium responses were virtually absent, thus very closely related to those of MOAT group 1 patients. In this respect, the calcium oscillatory pattern analysis showed that an underlying sperm deficiency remains the most plausible cause of failed fertilization for these cases. Importantly, also in the remaining MOAT group 2 patients, lower amplitudes and fewer oscillating oocytes were seen compared with the MOAT group 3 patients and the frozen -thawed control group. Commonly, for MOAT group 2 patients, strongly dissimilar calcium oscillatory patterns were seen when compared with control samples. Interestingly, detailed analysis of the calcium oscillatory patterns seen in this group of patients revealed that they were more closely related to MOAT group 1 patients than MOAT group 3 patients or the fertile controls. The latter was especially clear from the analysis of the frequency × amplitude product, which demonstrated a significantly lower value for MOAT group 1 and 2 Significant difference between the four study groups with P , 0.001 ( x 2 ) and P , 0.001 (one-way ANOVA).
b
Significantly different from MOAT group 3 and frozen-thawed control with P , 0.01 and P , 0.01, respectively (Mann -Whitney U-test).
c Significantly different from MOAT group 3 and frozen-thawed control with P , 0.01 and P , 0.05, respectively (Mann -Whitney U-test). Significantly different from MOAT group 3 and frozen-thawed control with P , 0.01 and P , 0.05, respectively (Mann -Whitney U-test).
e Significantly different from MOAT group 3 and frozen-thawed control with P , 0.01 and P , 0.05, respectively (Mann-Whitney U-test).
f Significantly different from MOAT group 3 and frozen-thawed control with P , 0.01 and P , 0.01, respectively (Mann -Whitney U-test).
g Significantly different from MOAT group 3 and frozen-thawed control with P , 0.01 and P , 0.05 , respectively (Mann -Whitney U-test).
when compared with MOAT group 3 and the frozen -thawed control samples. Finally, the fact that all but one MOAT group 2 patients lie below the horizontal line through the vertex point of the hyperbolic function supports a clearly distinctive property of the amplitude × frequency product for this group. Combined, the results of the former MOAT and the current calcium oscillation pattern analysis indicate that MOAT group 2 should be considered as having a sperm-related deficiency. According to the threshold created by multiplying the frequency with the amplitude of the measured calcium spikes, two formerly MOAT group 3 cases (cases 3.6 and 3.7) would have been divided into the group in which a sperm deficiency is nonetheless suspected (product lower than the threshold). Firstly, according to the proposed diagnostic and therapeutic algorithm in Fig. 5 , these cases would not have been advised to undergo calcium oscillatory pattern analysis in addition to the original MOAT. Secondly, in these two cases AOA was performed on a part of their sibling oocytes in a next treatment cycle, and indeed, AOA yielded a higher fertilization rate compared with conventional ICSI. The latter strategy is the best possible strategy for this group of patients, in order to decide on further treatment possibilities, and was proposed earlier (Vanden Meerschaut et al., 2012).
Not much is known yet about the influence of aberrant calcium oscillatory patterns, such as found in MOAT group 2 patients, on embryo development. Several studies demonstrate that calcium transient number, frequency, amplitude and duration can regulate individual cellular processes (Berridge et al., 2000) . On the other hand, others propose that the summation of the calcium signal results in egg activation when the total dose of calcium stands above a minimum threshold (Tó th et al., 2006) . In the mouse, calcium release is essential for both early and late events of oocyte activation, such as cortical granule exocytosis, cell cycle resumption and the recruitment of maternal mRNA (Xu et al., 1994; Ducibella et al., 2002; Ozil et al., 2005) and further pre-and post-implantation embryo development . Importantly, the results of the calcium analysis in mouse oocytes should not be directly extrapolated to human oocytes. Human PLCzeta exhibits a greater potency in mouse oocytes compared with mouse PLCzeta Ito et al., 2008) . Also, it has been reported that the activation rate of mouse eggs after ICSI of sperm from one patient was almost doubled when two instead of one spermatozoa were injected, indicating that in some patients the oocyte-activating defect of spermatozoa can also have a quantitative aspect (Yanagida et al., 1999) . We speculate that a minimal amount of human PLCzeta present in semen of Figure 3 Calcium patterns seen after injection of MOAT group 2 sperm. Representative traces of the strongly dissimilar calcium patterns seen after heterologous ICSI using human sperm with intermediate activating capacity (the particular case from which the pattern was taken is mentioned above the graph) (AU, arbitrary units). Figure 5 Diagnostic and therapeutic algorithm. Diagnostic and therapeutic approach based on the MOAT activation result for patients with previous total fertilization failure or low fertilization rates following conventional ICSI in recurrent cycles. The dollar sign ($) denotes the threshold, which is based on the amplitude × frequency value of the vertex point (Fig. 4B) MOAT group 2 patients might have been able to cause a few calcium oscillations in mouse oocytes, whereas in human oocytes this might not have been the case. Therefore, it would be a matter of further research whether these patients' sperm bear abnormalities in the expression of the sperm factor or mutations in the gene. Moreover, whether human sperm with deficient oocyte activation capacity induce aberrant calcium responses in human oocytes as well and whether these affect embryonic development warrant further investigation.
In conclusion, sperm from 26 patients with a history of total fertilization failure or low fertilization rates after ICSI induced a variety of calcium responses in mouse oocytes following heterologous ICSI, ranging from a complete lack of calcium spikes to high frequency calcium spikes. For MOAT group 2 patients, whose sperm have an intermediate activation capacity according to the MOAT, calcium oscillatory pattern analysis had the strength to reveal, more clearly when compared with the classical MOAT, underlying reasons for low or failed fertilization after conventional ICSI. The frequency of the calcium spikes together with their amplitude (frequency × amplitude product) allowed us to create a new threshold value, which can help to confirm or refute, on a single patient base, a sperm-borne activation deficiency. The latter tool is crucial for further treatment advice and prognosis. When a sperm deficiency can be ascertained, AOA should be advised to the couple, since AOA has been proved to be very efficient in these cases regarding fertilization and pregnancy rates. When no sperm deficiency is presumed, an underlying egg factor should still be suspected and AOA is no longer a straightforward treatment. In those cases, AOA might be performed on part of the oocytes in a next treatment cycle (Heindryckx et al., 2008; Vanden Meerschaut et al., 2012) . Therefore, calcium oscillatory pattern analysis has a great diagnostic and prognostic potential in current clinical practice, especially for patients in the 'grey zone' with an intermediate inconclusive activation capacity according to the MOAT.
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